Home > Publications database > Genetically predicted circulating C-reactive protein concentration and colorectal cancer survival: A Mendelian randomization consortium study. > print

001     168784
005     20240229133616.0
024 7 _ |a 10.1158/1055-9965.EPI-20-1848
|2 doi
024 7 _ |a pmid:33972368
|2 pmid
024 7 _ |a 1055-9965
|2 ISSN
024 7 _ |a 1538-7755
|2 ISSN
024 7 _ |a altmetric:107828260
|2 altmetric
037 _ _ |a DKFZ-2021-01065
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Hua, Xinwei
|0 0000-0003-2114-2975
|b 0
245 _ _ |a Genetically predicted circulating C-reactive protein concentration and colorectal cancer survival: A Mendelian randomization consortium study.
260 _ _ |a Philadelphia, Pa.
|c 2021
|b AACR
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1627469969_3141
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Jul;30(7):1349-1358
520 _ _ |a A positive association between circulating C-reactive protein (CRP) and colorectal cancer (CRC) survival was reported in observational studies, which are susceptible to unmeasured confounding and reverse causality. We used a Mendelian randomization approach to evaluate the association between genetically-predicted CRP concentrations and CRC-specific survival.We used individual-level data for 16,918 eligible CRC cases of European ancestry from 15 studies within the International Survival Analysis of Colorectal Cancer Consortium. We calculated a genetic risk score based on 52 CRP-associated genetic variants identified from genome-wide association studies. Due to the non-collapsibility of hazard ratios from Cox proportional hazards models, we used the additive hazards model to calculate hazard differences (HD) and 95% confidence intervals (CI) for the association between genetically-predicted CRP concentrations and CRC-specific survival, overall and by stage at diagnosis and tumor location. Analyses were adjusted for age at diagnosis, sex, body mass index, genotyping platform, study, and principal components.Of the 5,395 (32%) deaths accrued over up to 10 years of follow-up, 3,808 (23%) were due to CRC. Genetically-predicted CRP concentration was not associated with CRC-specific survival (HD= -1.15, 95% CI: -2.76 to 0.47 per 100,000 person-years, P =0.16). Similarly, no associations were observed in subgroup analyses by stage at diagnosis or tumor location.Despite adequate power to detect moderate associations, our results did not support a causal effect of circulating CRP concentrations on CRC-specific survival.Future research evaluating genetically-determined levels of other circulating inflammatory biomarkers (i.e. interleukin-6) with CRC survival outcomes is needed.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
700 1 _ |a Dai, James Y
|b 1
700 1 _ |a Lindström, Sara
|b 2
700 1 _ |a Harrison, Tabitha A
|0 0000-0002-4173-7530
|b 3
700 1 _ |a Lin, Yi
|b 4
700 1 _ |a Alberts, Steven R
|b 5
700 1 _ |a Alwers, Elizabeth
|0 P:(DE-He78)9b2a61b2abe4a64ca23b6783b7c4fe63
|b 6
|u dkfz
700 1 _ |a Berndt, Sonja I
|b 7
700 1 _ |a Brenner, Hermann
|0 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
|b 8
|u dkfz
700 1 _ |a Buchanan, Daniel D
|0 0000-0003-2225-6675
|b 9
700 1 _ |a Campbell, Peter T
|0 0000-0002-5549-2036
|b 10
700 1 _ |a Casey, Graham
|b 11
700 1 _ |a Chang-Claude, Jenny
|0 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
|b 12
|u dkfz
700 1 _ |a Gallinger, Steven
|b 13
700 1 _ |a Giles, Graham G
|0 0000-0003-4946-9099
|b 14
700 1 _ |a Goldberg, Richard M
|0 0000-0003-0308-8223
|b 15
700 1 _ |a Gunter, Marc J
|b 16
700 1 _ |a Hoffmeister, Michael
|0 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
|b 17
|u dkfz
700 1 _ |a Jenkins, Mark A
|b 18
700 1 _ |a Joshi, Amit D
|b 19
700 1 _ |a Ma, Wenjie
|b 20
700 1 _ |a Milne, Roger L
|0 0000-0001-5764-7268
|b 21
700 1 _ |a Murphy, Neil
|b 22
700 1 _ |a Pai, Rish K
|0 0000-0002-2692-221X
|b 23
700 1 _ |a Sakoda, Lori C
|0 0000-0002-0900-5735
|b 24
700 1 _ |a Schoen, Robert E
|0 0000-0001-7153-2766
|b 25
700 1 _ |a Shi, Qian
|b 26
700 1 _ |a Slattery, Martha L
|0 0000-0002-1655-6543
|b 27
700 1 _ |a Song, Mingyang
|b 28
700 1 _ |a White, Emily
|b 29
700 1 _ |a Le Marchand, Loic
|b 30
700 1 _ |a Chan, Andrew T
|b 31
700 1 _ |a Peters, Ulrike
|0 0000-0001-5666-9318
|b 32
700 1 _ |a Newcomb, Polly A
|b 33
773 _ _ |a 10.1158/1055-9965.EPI-20-1848
|g p. cebp.1848.2021 -
|0 PERI:(DE-600)2036781-8
|n 7
|p 1349-1358
|t Cancer epidemiology, biomarkers & prevention
|v 30
|y 2021
|x 1538-7755
909 C O |o oai:inrepo02.dkfz.de:168784
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)9b2a61b2abe4a64ca23b6783b7c4fe63
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)c259d6cc99edf5c7bc7ce22c7f87c253
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 17
|6 P:(DE-He78)6c5d058b7552d071a7fa4c5e943fff0f
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Cancer risk factors and prevention
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CANCER EPIDEM BIOMAR : 2019
|d 2021-02-02
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-02
920 1 _ |0 I:(DE-He78)C070-20160331
|k C070
|l C070 Klinische Epidemiologie und Alternf.
|x 0
920 1 _ |0 I:(DE-He78)C120-20160331
|k C120
|l Präventive Onkologie
|x 1
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 2
920 1 _ |0 I:(DE-He78)HD01-20160331
|k HD01
|l DKTK HD zentral
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C070-20160331
980 _ _ |a I:(DE-He78)C120-20160331
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a I:(DE-He78)HD01-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21